Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
3.840
+0.100 (2.67%)
At close: Dec 5, 2025, 4:00 PM EST
3.770
-0.070 (-1.82%)
After-hours: Dec 5, 2025, 6:01 PM EST
Minerva Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | - | - | 41.18 | |
| Cost of Revenue | 5.57 | 11.9 | 12.71 | 14.65 | 16.84 | 22.04 | |
| Gross Profit | -5.57 | -11.9 | -12.71 | -14.65 | -16.84 | 19.14 | |
| Selling, General & Admin | 9.07 | 9.95 | 10.41 | 10.58 | 13.33 | 17.29 | |
| Operating Expenses | 9.07 | 9.95 | 10.41 | 10.58 | 13.33 | 17.29 | |
| Operating Income | -14.64 | -21.85 | -23.12 | -25.23 | -30.17 | 1.85 | |
| Interest Expense | - | -4.56 | -8.28 | -7.41 | -6.33 | - | |
| Interest & Investment Income | 0.64 | 1.27 | 1.44 | 0.56 | 0.02 | 0.16 | |
| Currency Exchange Gain (Loss) | -0.03 | -0 | -0.04 | -0.03 | -0.03 | -0.07 | |
| Other Non Operating Income (Expenses) | - | 26.58 | - | - | - | - | |
| EBT Excluding Unusual Items | -14.03 | 1.44 | -30.01 | -32.11 | -36.51 | 1.94 | |
| Asset Writedown | - | - | - | - | -15.2 | - | |
| Pretax Income | -14.03 | 1.44 | -30.01 | -32.11 | -51.71 | 1.94 | |
| Income Tax Expense | - | - | - | - | -1.8 | - | |
| Net Income | -14.03 | 1.44 | -30.01 | -32.11 | -49.91 | 1.94 | |
| Net Income to Common | -14.03 | 1.44 | -30.01 | -32.11 | -49.91 | 1.94 | |
| Shares Outstanding (Basic) | 8 | 8 | 7 | 5 | 5 | 5 | |
| Shares Outstanding (Diluted) | 8 | 8 | 7 | 5 | 5 | 5 | |
| Shares Change (YoY) | -0.04% | 16.41% | 21.84% | - | 4.41% | 4.88% | |
| EPS (Basic) | -1.85 | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 | |
| EPS (Diluted) | -1.85 | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 | |
| Free Cash Flow | -14.2 | -19.55 | -14.78 | -24.66 | -24.6 | -33.82 | |
| Free Cash Flow Per Share | -1.88 | -2.58 | -2.27 | -4.62 | -4.61 | -6.61 | |
| Gross Margin | - | - | - | - | - | 46.48% | |
| Operating Margin | - | - | - | - | - | 4.49% | |
| Profit Margin | - | - | - | - | - | 4.71% | |
| Free Cash Flow Margin | - | - | - | - | - | -82.14% | |
| EBITDA | -14.64 | -21.84 | -23.11 | - | -30.15 | 1.86 | |
| EBITDA Margin | - | - | - | - | - | 4.52% | |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | - | 0.02 | 0.02 | |
| EBIT | -14.64 | -21.85 | -23.12 | -25.23 | -30.17 | 1.85 | |
| EBIT Margin | - | - | - | - | - | 4.49% | |
| Revenue as Reported | - | - | - | - | - | 41.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.